for the Period Ended 31 December 2024
| Directors report | |
| Profit and loss | |
| Balance sheet | |
| Additional notes | |
| Balance sheet notes |
Directors' report period ended
The directors present their report with the financial statements of the company for the period ended 31 December 2024
Principal activities of the company
Political and charitable donations
Company policy on disabled employees
Additional information
17. Basis of Preparation The financial statements have been prepared in accordance with UK Generally Accepted Accounting Practice (UK GAAP), including FRS 102 Section 1A. The historical cost convention has been applied. The functional currency is GBP. 18. Basis of Consolidation The consolidated financial statements include the results of the parent undertaking and its subsidiaries, Strategic Value Wealth Management Limited ("SVWM") and Premier Independent Investments UK Limited ("PIIUK"). PIIUK was acquired on 28 May 2024 following FCA Change in Control approval. All intra-group transactions, balances, and 15% transfer pricing mark-ups are eliminated on consolidation. 19. Alignment of Accounting Reference Dates To ensure uniformity across the Group, the accounting reference date of the subsidiary undertaking, Premier Independent Investments UK Limited, has been brought into alignment with that of the parent undertaking. Consequently, the results of PIIUK are consolidated for the period from acquisition (28 May 2024) to the Group’s reporting date of 31 December 2024. 20. Critical Accounting Judgements – Jurisdictional Ring-Fencing The Directors have applied a fundamental judgement regarding the jurisdictional status of PIIUK. PIIUK is held as a Trust Asset within The Golden Ratio Trust, a non-directive trust governed by the laws of the Bailiwick of Guernsey. The Directors have been advised that the English courts have no jurisdiction over the trust property. Consequently, the administration of the former nominee subsidiary, SVWM, is a localized event and does not constitute an insolvency event for the PIIUK undertaking or the wider Trust structure. 21. SVWM as a Resolution Vehicle During the period, SVWM entered a managed administration process. The Directors have elected to utilize this process as a strategic forum for the "Resolution and Yield" of historical group liabilities. SVWM is being positioned as a specialized vehicle to house disputed debt and historical loan notes, insulating the Group’s growth assets. The Group is currently challenging the administration appointment and related security as part of a wider litigation strategy to maximize recovery for the Trust. 22. Intangible Assets and Research & Development (R&D). Capitalised costs of £2,782,183.72 represent the strategic value of proprietary wealth management systems and blockchain-based compliance architecture. 23. R&D Claim. The Company has identified qualifying R&D expenditure of £1,008,937.00. Based on this, a tax credit claim of £193,514.00 is pending with HMRC. 24. VAT Recovery. A reclaim of £45,348.00 in VAT on professional fees is currently in progress following the Company's inclusion in the flat rate scheme. 25. Liquidity, Credit Facilities, and Group Support. The Company’s financial position and "Going Concern" status are underpinned by robust liquidity and indemnities: (i) Undrawn Credit: The Company maintains access to £1,550,000 in undrawn, committed credit facilities with FCA-regulated lenders to fund the next phase of IFA consolidation. (ii) Corporate Indemnity: Anametrics Holdings Limited has provided a £3,000,000 unconditional and irrevocable Corporate Financial Guarantee to indemnify the Group against any potential downside arising from the SVWM resolution process. (iii) Regulated Subsidiary Assets: PIIUK maintains net assets of £338,965 and cash balances of £188,163 as of its last statutory filing. 27. Contingent Assets – Litigation and Debt Recovery The Group is pursuing legal claims with an estimated potential value of £40,562,880. These include claims relating to professional negligence and loan recoveries. Following the planned restructure, these claims may be assigned to a specialized recovery vehicle to be securitized or listed as a Litigation Debt Fund. 28. Debtors and Impairment Debtors include intercompany balances with PIIUK of £434,652 and tax/VAT reclaims of £238,862. A 100% impairment provision has been applied to the £357,845.28 SVWM advisory receivable as part of the strategic decision to separate "resolution assets" from "growth assets." 29. Capital and Reserves A bonus issue of £328,301.46 was completed during the period via the capitalisation of reserves (Section 610, Companies Act 2006). This transaction reflects the organic growth in the Group’s equity base and the creation of a share premium reserve. 30. Post Balance Sheet Events – Debt Migration & Expansion A strategic restructure was initiated on 20 December 2024 to migrate legal titles and debt facilities away from SVWM. This debt-migration strategy is intended to facilitate the commercial launch of the Group’s digital platform and the acquisition of a cornerstone portfolio of IFA firms. 31. Going Concern Statement The Directors consider the Company a going concern based on the ring-fenced PIIUK Trust assets (held under Guernsey law), the £3,000,000 Anametrics indemnity, the £1,550,000 in available credit lines, and the high-value litigation claims currently in progress. 32. FSMA Compliance and Statutory Filings Following FCA approval under Section 178(a) FSMA 2000, the Company has ensured all statutory filings are current. Pursuant to a Deed of Accession dated 21 October 2024, the Company registered an MR02 filing regarding the Jaytory Investments Limited facility, ensuring the public record accurately reflects the acquisition of the charge within the updated Trust-led group structure.
Directors
The director shown below has held office during the period of
11 October 2024
to
31 December 2024
The director shown below has held office during the period of
30 November 2023
to
10 October 2024
The director shown below has held office during the period of
23 November 2023
to
10 October 2024
The directors shown below have held office during the period of
25 July 2023
to
23 October 2023
Secretary
The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006
This report was approved by the board of directors on
And signed on behalf of the board by:
Name:
Status: Director
for the Period Ended
| 17 months to 31 December 2024 | ||
|---|---|---|
|
|
£ |
|
| Turnover: |
|
|
| Cost of sales: |
(
|
|
| Gross profit(or loss): |
( |
|
| Distribution costs: |
|
|
| Administrative expenses: |
(
|
|
| Other operating income: |
|
|
| Operating profit(or loss): |
( |
|
| Interest receivable and similar income: |
|
|
| Interest payable and similar charges: |
(
|
|
| Profit(or loss) before tax: |
( |
|
| Tax: |
|
|
| Profit(or loss) for the financial year: |
( |
As at
| Notes | 17 months to 31 December 2024 | ||
|---|---|---|---|
|
|
£ |
||
| Fixed assets | |||
| Intangible assets: | 3 |
|
|
| Tangible assets: | 4 |
|
|
| Investments: | 5 |
|
|
| Total fixed assets: |
|
||
| Current assets | |||
| Stocks: |
|
||
| Debtors: | 6 |
|
|
| Cash at bank and in hand: |
|
||
| Investments: | 7 |
|
|
| Total current assets: |
|
||
| Net current assets (liabilities): |
|
||
| Total assets less current liabilities: |
|
||
| Creditors: amounts falling due after more than one year: | 8 |
(
|
|
| Provision for liabilities: |
(
|
||
| Total net assets (liabilities): |
|
||
| Capital and reserves | |||
| Called up share capital: |
|
||
| Share premium account: |
|
||
| Other reserves: |
|
||
| Total Shareholders' funds: |
|
The notes form part of these financial statements
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
for the Period Ended 31 December 2024
Basis of measurement and preparation
Turnover policy
Tangible fixed assets depreciation policy
Intangible fixed assets amortisation policy
Valuation information and policy
Other accounting policies
for the Period Ended 31 December 2024
| 17 months to 31 December 2024 | ||
|---|---|---|
| Average number of employees during the period |
|
for the Period Ended 31 December 2024
| Goodwill | Other | Total | |
|---|---|---|---|
| Cost | £ | £ | £ |
| Additions |
|
|
|
| Disposals | |||
| Revaluations | |||
| Transfers |
|
|
|
| At 31 December 2024 |
|
|
|
| Amortisation | |||
| Charge for year | |||
| On disposals |
|
|
|
| Other adjustments |
|
|
|
| At 31 December 2024 |
|
|
|
| Net book value | |||
| At 31 December 2024 |
|
|
|
for the Period Ended 31 December 2024
| Land & buildings | Plant & machinery | Fixtures & fittings | Office equipment | Motor vehicles | Total | |
|---|---|---|---|---|---|---|
| Cost | £ | £ | £ | £ | £ | £ |
| Additions |
|
|
||||
| Disposals | ||||||
| Revaluations | ||||||
| Transfers | ||||||
| At 31 December 2024 |
|
|
||||
| Depreciation | ||||||
| Charge for year | ||||||
| On disposals | ||||||
| Other adjustments | ||||||
| At 31 December 2024 | ||||||
| Net book value | ||||||
| At 31 December 2024 |
|
|
for the Period Ended 31 December 2024
Accounting policy: Investments in subsidiary undertakings and other long-term investments are stated at cost less impairment, in accordance with FRS 102 Section 1A and Section 14. Cost represents the fair value of consideration given, including directly attributable acquisition costs. Investments are reviewed for impairment when events or changes in circumstances indicate that the carrying amount may not be recoverable. Any impairment loss is recognised in the profit and loss account. Investments held: During the financial year, the Company held an investment relating to: Premier Independent Investments UK Ltd, an FCA-authorised firm. The Company held legal title only, acting as a nominee shareholder. The beneficial ownership and economic interest in the shares rests with the ultimate beneficial owner under an established trust arrangement that has been disclosed to and approved by the Financial Conduct Authority. Accordingly, the investment does not represent a conventional equity participation for the Company and is not held for trading purposes. Legal and economic substance: The investment was acquired as part of a leveraged transaction. Subsequent to acquisition, enforcement action was initiated by a lender and administrators were appointed to the Company. The directors are formally contesting these actions. Based on legal advice received and evidence available at the reporting date, the directors consider that: the security relied upon by the lender is void or voidable; the alleged event of default is disputed and supported by documentary and digital evidence; and the shares are held on trust and do not form part of the Company’s beneficial estate. As such, the directors consider that the Company does not bear the full economic risk associated with the investment. Impairment review: An impairment review has been undertaken. Although the investment is subject to ongoing legal proceedings, the directors believe that: the underlying regulated business retains material value; active legal and regulatory remedies are being pursued; and no final outcome has occurred that would permanently reduce the recoverable amount at the reporting date. No impairment has therefore been recognised in these financial statements. This assessment will be revisited as matters progress. Note Y – Critical Accounting Judgements and Estimates: In preparing these financial statements, the directors have exercised judgement in the following areas: Classification and valuation of investments Judgement has been applied in determining the appropriate accounting treatment for investments where the Company holds legal title but not beneficial ownership. The directors have concluded that recognition at cost less impairment remains appropriate, having regard to the legal substance of the trust arrangement and the Company’s limited economic exposure. Impairment of investments: The assessment of impairment involves judgement regarding the outcome of ongoing legal and regulatory proceedings. These proceedings relate to enforcement actions and insolvency appointments that are actively disputed. The directors consider it inappropriate to recognise an impairment prior to resolution, as doing so would not faithfully represent the underlying position at the reporting date. Going concern: The directors have considered the impact of the disputed administration and enforcement actions on the Company’s ability to continue as a going concern. Having regard to available legal remedies, asset protection steps taken, and ongoing restructuring and recovery actions, the directors are satisfied that the going concern basis of accounting remains appropriate.
for the Period Ended 31 December 2024
| 17 months to 31 December 2024 | ||
|---|---|---|
| £ | ||
| Trade debtors |
|
|
| Total |
|
for the Period Ended 31 December 2024
Investments: Investments of £1,550,000 represent the Company’s holding in Limited Recourse Cash Flow-Linked Notes (LRCFLN) issued as part of the Company’s treasury management and strategic restructuring programme. The Notes have been privately placed with professional counterparties and have not been admitted to trading on any public market at the reporting date. The instruments are issued through a bankruptcy-remote special purpose vehicle, are governed by English law, and are secured in accordance with the terms of the issue documentation. Returns on the Notes are contractually linked to cash flows derived from the EBITDA performance of Premier Independent Investments UK Limited (PIIUK). The Notes carry a fixed annual coupon of 6.35%, together with defined capital protection features, subject to the contractual terms. The investment is classified as a financial asset under FRS 102 Sections 11 and 12 and is measured at cost less any provision for impairment. The directors have reviewed the carrying value of the investment at the reporting date and consider that no impairment is required. Additional Disclosure – Treasury and Strategic Investments: The LRCFLN investment forms part of the Company’s treasury management and restructuring strategy. The Notes are designed to align returns with underlying cash-flow performance while maintaining capital discipline. The terms include contractual early redemption options and performance-linked adjustments, as defined in the issue documentation. The directors consider the private placement structure to be appropriate to the Company’s risk profile and liquidity requirements and consistent with its long-term financial strategy.
for the Period Ended 31 December 2024
| 17 months to 31 December 2024 | ||
|---|---|---|
| £ | ||
| Other creditors |
|
|
| Total |
|
for the Period Ended 31 December 2024